ALGERT GLOBAL LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$437,000
+75.5%
12,920
+50.1%
0.03%
+36.8%
Q2 2022$249,000
+13.7%
8,608
+27.0%
0.02%
+35.7%
Q1 2022$219,000
+3.3%
6,778
-14.8%
0.01%
-50.0%
Q3 2021$212,000
-53.2%
7,955
-58.3%
0.03%
-79.3%
Q4 2019$453,000
-61.8%
19,090
-55.7%
0.14%
-69.5%
Q3 2019$1,185,000
+61.2%
43,123
+94.2%
0.44%
+62.5%
Q2 2019$735,000
+11.9%
22,210
+18.4%
0.27%
-27.5%
Q1 2019$657,000
-22.1%
18,758
-26.0%
0.38%
+59.6%
Q4 2018$843,000
+107.6%
25,363
+214.6%
0.24%
+167.0%
Q3 2018$406,000
-15.8%
8,0610.0%0.09%
-12.0%
Q2 2018$482,000
-90.5%
8,061
-92.7%
0.10%
-89.9%
Q1 2018$5,092,000
+91.1%
111,183
+66.3%
0.99%
+56.8%
Q4 2017$2,664,000
+6.3%
66,863
+6.7%
0.63%
+9.8%
Q3 2017$2,507,000
+12.4%
62,681
+21.1%
0.57%
-8.5%
Q2 2017$2,231,000
+21.6%
51,767
-11.7%
0.63%
+26.2%
Q1 2017$1,835,00058,6120.50%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders